Characteristics and advantages of adeno-associated virus vector-mediated gene therapy for neurodegenerative diseases931-938
Gene expression changes in dorsal root ganglia following peripheral nerve injury: roles in inflammation, cell death and nociception939-947
Nicotinamide adenine dinucleotide phosphate oxidase activation and neuronal death after ischemic stroke948-953
Autophagy: novel insights into therapeutic target of electroacupuncture against cerebral ischemia/reperfusion injury954-961
Lessons from glaucoma: rethinking the fluid-brain barriers in common neurodegenerative disorders962-966
Muscle secretion of toxic factors, regulated by miR126-5p, facilitates motor neuron degeneration in amyotrophic lateral sclerosis969-970
Preliminary in vitro evaluation of neuroprotective and monoamine oxidase type B inhibitory effects of newly synthesized 8-aminocaffeines971-972
Therapeutic exploitation of the S-nitrosoglutathione/S-nitrosylation mechanism for the treatment of contusion spinal cord injury973-974